🔎 Trials Near Me

Akèy › Lukemi lenfositè kwonik › New Jersey › Clifton

Etid klinik pou Lukemi lenfositè kwonik nan Clifton, NJ

7 etid pou Lukemi lenfositè kwonik ap chèche patisipan nan sit nan ak bò kote Clifton (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Ap rekriteFaz 1/2
  • Research Site, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06542250

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Ap rekriteFaz 3
  • John Theurer Cancer Center Hackensack University Medical Center, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06973187

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Ap rekriteFaz 3
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0016), Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06136559

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Ap rekriteFaz 1/2
  • Research Site, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06564038

Study of SGR-1505 in Mature B-Cell Neoplasms

Ap rekriteFaz 1
  • Regional Cancer Care Associates, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT05544019

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Ap rekriteFaz 2
  • Regional Cancer Care Associates /ID# 244620, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 9, 2026 · NCT04895436

Etid Lukemi lenfositè kwonik nan lòt vil

Lòt etid nan Clifton

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.